Virtual Presentation

ALL in Special Populations: Adolescents/Young Adults and Older Adults

Source: Current Treatment Options in Acute Lymphoblastic Leukemia

ALL in Special Populations: Adolescents/Young Adults and Older Adults

Program Director: Martin S. Tallman, MD

Faculty:

Adele K. Fielding, MB BS, PhD, FRCP, FRCPath

CREDIT INFORMATION

Release Date: 04/23/09

Expiration Date: 04/22/10

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Identify factors that contribute to age-related differences in outcomes in adult patients with acute lymphoblastic leukemia (ALL)
Describe the differences between adult and pediatric ALL treatment protocols
Discuss strategies to optimize outcomes in adolescent/young adult patients with ALL
Examine treatment considerations for older adults with ALL

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.